Article content material
- Paola Casarosa appointed member of the Board of Managing Administrators per July 1, 2023, with accountability for the Innovation Unit per January 1, 2024.
- Shashank Deshpande appointed member of the Board of Managing Administrators per September 1, 2023, with accountability for the Animal Well being Enterprise Unit per January 1, 2024.
- Michel Pairet and Jean Scheftsik de Szolnok to retire on the finish of 2023.
INGELHEIM AM RHEIN, Germany — Boehringer Ingelheim right now pronounces that the Shareholders have appointed Paola Casarosa and Shashank Deshpande to the Board of Managing Administrators. They’ll succeed Michel Pairet, chargeable for the Innovation Unit, and Jean Scheftsik de Szolnok, chargeable for the Animal Well being Enterprise Unit, who knowledgeable the Shareholders of their want to retire on the finish of subsequent yr.
Article content material
Paola Casarosa will succeed Michel Pairet to move the Innovation Unit. Paola joined Boehringer Ingelheim in 2007 and is presently World Head of Therapeutic Areas within the Human Pharma Enterprise Unit. Previous to this position, she held numerous management roles in Enterprise Growth and in Analysis. Paola is an Italian nationwide, holds a PhD in Molecular Pharmacology and a Masters’ diploma in Medicinal Chemistry.
Shashank Deshpande will succeed Jean Scheftsik de Szolnok to move the Animal Well being Enterprise Unit. Shashank joined Boehringer Ingelheim in 2012 and is presently Nation Managing Director Japan. Previous to this position he held a number of management and advertising positions in Japan and Ingelheim. A German and US nationwide, Shashank holds a Masters’ diploma in Enterprise Administration.
Christian Boehringer, Chairman of the Shareholders’ Committee mentioned: “Our long-term planning permits for a seamless transition. On behalf of the Shareholders, I need to thank Michel and Jean for his or her a few years of dedication to our firm and I congratulate Paola and Shashank on their appointments.”
Hubertus von Baumbach, Chairman of the Board of Managing Administrators, added: “I’m grateful for the very long time that I’ve had the privilege to work with Michel and Jean and I stay up for persevering with to work with them till the top of 2023. The Board is worked up to welcome Paola and Shashank to the staff later subsequent yr.”
The appointment to the Board of Managing Administrators will likely be efficient July 1, 2023 for Paola Casarosa and September 1, 2023 for Shashank Deshpande.
Click on right here for the complete launch: https://www.boehringer-ingelheim.com/about-us/boehringer-ingelheim-appointment-board-managing-directors
View supply model on businesswire.com: https://www.businesswire.com/information/dwelling/20221220005424/en/
Contacts
Contact individual:
Médard Schoenmaeckers
Boehringer Ingelheim Company Affairs
Electronic mail: [email protected]
#distro
